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INTRODUCTION 
Periodontal disease affects about 10-15% of the popula-
tion worldwide [1]. Periodontal disease is now known to 
be a primarily a systemic disease that simply manifest in 
the oral cavity. More that 90% of systemic diseases re-
veal signs and symptoms in mouth [2]. 
At present, periodontitis, its destructive phase, is consid-
ered to be initiated and perpetuated by a small group of 
predominantly gram-negative, anaerobic, or micro-
aerophilic bacteria that colonize the subgingival area. 
There is a delicate balance between inflammatory and 
immune cells hypofunction where unchecked pathogens 
cause direct tissue damage and hyperfunction, where 
hosts defence cell products elaborated in all effort to                                
eliminate pathogens inadvertently cause substantial col-
lateral host tissue damage [3]. Tissue infiltration by pol-
ymorphonuclear leukocytes and monocytes and subse-
quent phagocytosis, features a burst of cyanide insensi-
tive (i.e., non-mitochondrial) O2 consumption, which 
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may be 10 or 20 times that of resting consumption [4]. 
Until now, primary clinical weapons against periodontal 
disease have been scaling and root planning (SRP), anti-
biotics and surgery. Clinical research says that SRP is 
ineffective up to 40% of time and when it does work, 
SRP reduces pocket depths by a little over 1mm on an 
average. Also, SRP is topical and it does nothing to de-
crease the systemic nature of periodontitis. Antioxi-
dants, if given, can act systemically to support the 
body’s natural immune system. 
Melatonin is a ubiquitous natural neurotransmitter like 
compound produced primarily by pineal gland [5]. The 
role of endogenous melatonin in circadian rhythm dis-
turbances and sleep disorders is well established [6]. 
Subsequently, melatonin was shown to have significant-
ly broader action including oncostatic effects, immune 
system stimulation and anti-inflammatory functions. 
Furthermore, many studies have proved that salivary, 
melatonin level varies according to the degree of perio-
dontal disease indicating that salivary melatonin may 
act to protect the body from external body insults. 
Therefore, melatonin supplementation, i.e., synthetic 
version of hormone melatonin may be potentially valua-
ble in the treatment of periodontal diseases [7]. 
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Considering the above-mentioned functions of melato-
nin, this study was designed to evaluate the ability of 
melatonin supplementation to reduce the periodontal 
inflammation.  
MATERIAL AND METHODOLOGY  
Study design: The present study was a Prospective lon-
gitudinal study 
Ethics approval: The study commenced after the ap-
proval of Institutional ethical committee Pravara Insti-
tute of Medical Sciences. Patients satisfying the inclu-
sion and exclusion criteria were included in the study 
after taking their written informed consent. 
Research place: Collaboration with the Department of 
Periodontics & Oral Implantology, Rural Dental Col-
lege and Department of Biochemistry, Rural Medical 
College & Hospital, Loni.  
Study period: One year  
Study population: The subjects enrolled for this study 
were selected from the out-patient Department of Perio-
dontics, Rural Dental College, Loni 
Inclusion criteria: Patients of chronic periodontitis, of 
age between 18 to 65 years of either gender ready to 
give informed consent to participate in the study were 
included.  
Exclusion criteria: Postoperative patients, patients hav-
ing night duties, drivers and those using heavy machin-
ery, pregnant women, lactating mothers, patients with 
any clinically significant systemic disease and patients 
on any other drugs were excluded from the study. 
Grouping: Depending on the treatment received, the 
patients were divided into two groups as Group A in-
cluded patients who underwent SRP (Scaling and Root 
Planning) alone, Group B who underwent SRP & sup-
plemented with tablet melatonin 3 mg daily at night for 
4 weeks. 
Methodology:  
The study participants visited on day 0 (visit 1), day 30 
(visit 2), day 60 (visit 3) and day 90 (visit 4). During the 
baseline visit scaling and root planning was performed 
in all patients. During these visits the Total leukocyte 
count (TLC), Differential leukocyte count (DLC) and 
Erythrocyte sedimentation rate (ESR) were studied. 
RESULTS  
Figure 1 shows the age and sex wise distribution of the 
subjects in the groups under study. Both the groups con-
sisted of 80 subjects each. Group A consisted of 71.25% 
male and 28.75% female patients. There were 56.25% 
male and 43.75% female patients in Group B. 
*P= 0.01 vs A (Z test for difference between two sam-
ple means)  
Table No. 1 shows the distribution of values of Total 
Leukocyte Count (TLC) in both groups at all visits. The 
TLC fell with each visit in Group A, while it increases 
during the visit 2 in the Group B. On comparing the 
groups with respect to TLC, there was no statistically 
significant difference between the groups with respect 
to baseline visit and visit 1. With respect to visit 3, the 
TLC was statistically lower in Group B. 
Fig 1: Age and sex wise distribution of the subjects 
under study  
Table  1: Total Leukocyte Count of patients during four 
visits in groups under study. 
Table No. 2 shows the distribution of values Neutro-
phils (N), Lymphocytes (L), Eosinophols (E), Mono-
cytes (M), Basophils (B) count in groups at all visits. 
The neutrophil count of Group B was significantly low-
er during visit 3 as compared to Group A. The lympho-
cyte count of Group B was significantly lower than that 
of Group A during the visit 1, and also significantly 
higher during visit 3 on comparison with Group A. 
There was no statistically significant difference in the 
groups with respect to eosinophil and basophil count. 
The Monocyte count of Group B was statistically lower 
when compared to that of Group A. All other compari-
sons were not statistically significant. 
Figure 2 shows the distribution of values of Erythrocyte 
Sedimentation Rate (ESR) in all groups at all visits. 
There was no statistically significant difference between 
ESR of Group A when compared with Group B during 
all visits.  
DISCUSSION 
As described in ‘Observations’, 160 diagnosed patients 
of periodontitis participated in the study, consisting of 
80 patients in each group. The percentage of male pa-
tients was higher than their female counterparts in both 
the groups.  




Group A Group B 
Mean ± SD Mean ± SD 
Base line visit 9117.5±2103.9 9370±2278.7 
Visit 1st 9112.5±2098.4 8916.2±1868.1 
Visit 2nd 8886.2±1783.5 9205.5±1719.6 
Visit 3rd 8531.6±1555.4 7593.7±1493.2* 
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Table 2: Differential Leukocyte Count of patients    
during four visits in groups under study. 
Fig 2: Erythrocyte Sedimentation Rate of patients dur-
ing four visits in groups under study. 
There was a highly significant difference between mean 
values of TLC when groups were compared at 3rd visit 
(p<0.01). TLC is considered as one of the inflammatory 
signs. Thus, these finding could depict that it took time 
after administration of study drugs to lower the level of 
TLC. But melatonin was again superior to group A in 
lowering the levels of TLC from pretreatment to post 
treatment levels.  No comparable study could be found 
in literature done in humans. 
There was a highly significant decrease in the mean 
values of neutrophils and lymphocytes in group B when 
compared with group A at 3rd visit (p<0.01). Thus, these 
findings could suggest that melatonin has a better role in 
reducing the inflammatory mediators in the body. 
Regarding ESR, there was no significant difference be-
tween mean values of ESR when compared at all visits 
(p>0.05). 
In a study by Domple etal [8], the granulocyte count 
was higher in buffalos of control groups as compared to 
those treated with subcutaneous Melatonin. A signifi-
cant increase in total leukocytic count and lymphocyte 
percentage was found in broiler chicks (Ahmed etal [9], 
Abozahra et al [10]), rats (Anwar et al  [11]), immature 
chicks (Bernan et al [12]) and squirrels (Rai et al [13]). 
The findings the animal studies are similar to our study 
done in humans. While the exact mechanism behind the 
differential effect is still not known, the postulated 
mechanisms consist of stimulation of bone marrow 
(Kuci et al. [14]), lymphatic tissue (Maestroni [15]), 
reduction in corticosterone hormone (Anwar et al [11]) 
or protection of bone marrow from damage by free radi-
cals due to its antioxidant effects (Ahmed et al [16]) 
In recent years, melatonin has been shown to play a 
fundamental role in neuro-immunomodulation. In vivo 
studies by Antonio Carrillo-Vico et al [17] show that 
melatonin exerts immune-enhancing properties by mod-
ulating cytokine production.  
Melatonin activates several elements of the immune 
system that reduce tissue destruction during the inflam-
matory response, either directly by free radical scaveng-
ing or indirectly by modulating the action of agents such 
as cytokines and adhesion molecules, which contribute 
to the advance of cell damage.  
CONCLUSION 
It can be concluded that melatonin has positive effect on 
TLC and differential count of patients of Periodontitis, 
conferring a new facet to the management of Periodonti-
tis and an attempt to impede the disease progression. To 
our knowledge, this is one of the first attempts to exam-
ine the influence of melatonin supplementation on peri-
odontal disease. Data from this study suggested a posi-
tive result in this regard. 
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